XT
CRMD icon

XTX Topco’s CorMedix CRMD Stock Holding History

XTX Topco’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-119,105
Closed -$809K – 4224
2026
Q1 		$809K Buy
+119,105
New +$880K 0.01% 1605
2025
Q4 		– Sell
-24,361
Closed -$283K – 3390
2025
Q3 		$283K Sell
24,361
-20,709
-46% -$250K 0.01% 1546
2025
Q2 		$555K Buy
45,070
+5,737
+15% +$63.3K 0.02% 1014
2025
Q1 		$242K Buy
39,333
+27,562
+234% +$285K 0.01% 1566
2024
Q4 		$95.3K Buy
+11,771
New +$118K 0.01% 1778
2023
Q4 		– Sell
-15,412
Closed -$57K – 1680
2023
Q3 		$57K Buy
+15,412
New +$61.3K 0.01% 1261
2022
Q4 		– Sell
-74,538
Closed -$211K – 1190
2022
Q3 		$211K Buy
74,538
+62,438
+516% +$260K 0.05% 748
2022
Q2 		$49K Buy
+12,100
New +$45K 0.02% 746

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

XTX Topco's CRMD Position: Q2 2026 in Review

XTX Topco sold out of CorMedix (CRMD) in Q2 2026, closing a stake of 119,105 shares — an estimated $809K sold.

XTX Topco first reported a position in CRMD in Q2 2022 and held it in 8 quarters. The position peaked at $809K in Q1 2026. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • XTX Topco reported no remaining CorMedix position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 119,105 CorMedix shares in Q2 2026, an estimated $809K.
  • XTX Topco first reported a position in CorMedix in Q2 2022 and held it in 8 quarters.
  • XTX Topco's CorMedix position peaked at $809K in Q1 2026.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.